Dr. Chennamadhavuni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Coffee Rd
Modesto, CA 95355Phone+1 209-550-4795
Education & Training
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2019 - 2020
Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 2017- Gundersen Lutheran Medical FoundationResidency, Internal Medicine, 2013 - 2016
Osmania Medical College NTR UHSClass of 2011
Certifications & Licensure
CA State Medical License 2021 - 2025
IA State Medical License 2017 - 2022
WI State Medical License 2016 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsPoly Adenosine Diphosphate-Ribose Polymerase (PARP) Inhibitors in Pancreatic Cancer.Tejasvi Sunkara, Sai Samyuktha Bandaru, Rajendra Boyilla, Rajesh Kunadharaju, Prithvi Kukkadapu
Cureus. 2022-02-01 - Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge.Adithya Chennamadhavuni, Pashtoon Murtaza Kasi
Frontiers in Oncology. 2022-01-01 - 93 citationsRisk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.Adithya Chennamadhavuni, Laith Abushahin, Ning Jin, Carolyn J Presley, Ashish Manne
Frontiers in Immunology. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
